据证监会官网，本周证监会国际司共对5家企业出具补充材料要求，其中包括冲刺港股的InxMedLimited （以下简称"应世生物"），证监会要求其新增股东有无入股对价异常，应世南京减资原因及是否涉及虚 假出资、抽逃出资等材料。 二、关于股权变动与股东情况： 具体来说，证监会请应世生物补充说明以下事项，请律师核查并出具明确的法律意见： 一、关于搭建离岸架构及返程并购的合规性，请说明: （1）公司及境内股东搭建离岸架构和返程投资涉及的外汇管理、境外投资、外商投资、税务管理等监 管程序具体履行情况，并说明是否符合当时有效监管规定的结论性意见； （2）公司取得境内运营实体的定价依据、支付手段、支付期限、定价的公允性，以及上述股权转让环 节相关转让方纳税申报义务履行情况，是否符合《关于外国投资者并购境内企业的规定》。 （1）请说明应世南京减资的原因及对价支付情况，是否涉及虚假出资、抽逃出资，并说明相关决策程 序履行及税费缴纳情况，是否符合《公司法》和税收相关法律法规规定； （2）请对照《监管规则适用指引——境外发行上市类第2号》，对应世北京历史上存在的股权代持的合 法合规性进行核查； （3）请就境内运营实体历次股权变动是 ...

公开资料显示，纳真科技是一家光通信与光连接解决方案的全栈式供货商，为AI算力网络提供最关键 的光通信产品，是全球少数同时拥有光模块和光芯片研发及量产能力的企业之一。 近年业绩有一定波动 业绩方面，纳真科技近几年业绩有一定的起伏波动。招股书显示，2022年至2024年，纳真科技的收入为 50.43亿元、42.39亿元、50.87亿元；年内溢利为4.29亿元、2.16亿元、8949万元。2025上半年，纳真科 技实现收入为42.16亿元，同比增长124%；期内溢利为5.1亿元，同比扭亏为盈。 盈利能力方面来看，2022-2024年，纳真科技整体毛利率分别为22.1%、20.6%和17.4%，2025年上半年 小幅上升至18.7%。与此同时，公司营收主力来源数通业务的毛利率也在持续下滑。 深圳商报·读创客户端记者 李薇 近日，中国证监会对拟赴港IPO的海信控股旗下纳真科技公司（简称"纳真科技"）出具了补充材料要 求，直指其历史沿革中"搭建离岸架构及返程并购"的合规性、一起关键诉讼对本次上市的影响等问题， 同时，本次发行上市的具体方案也受到关注。 今年8月底，纳真科技向港交所递交招股书，花旗和中信证券为其联席保荐人。 ...

Core Viewpoint - The China Securities Regulatory Commission (CSRC) has published supplementary material requirements for overseas listing applications, specifically requesting additional compliance information from Ligent Technologies, Inc. (纳真科技) regarding its offshore structure and reverse mergers [1][2]. Group 1: Compliance Requirements - The CSRC has requested Ligent Technologies to clarify the compliance of its offshore structure and reverse investment, including details on foreign exchange management, overseas investment, foreign investment, and tax management [1]. - The company must provide a conclusive opinion on the compliance of its acquisition of domestic operational entities, including the pricing basis, payment methods, and tax obligations related to share transfers [1][2]. Group 2: Shareholder and Legal Structure - Ligent Technologies is required to disclose the control structure of its major shareholder, Hisense Group, and whether any shareholders holding over 5% of shares have any legal restrictions on their holdings [2]. - The company must confirm the legality of past equity changes in its domestic operational entities and provide updates on any ongoing litigation, specifically regarding Qingdao Hisense Broadband [2]. Group 3: Listing and Investment Plans - The company needs to outline its plans for share subdivision and its impact on the number of shares to be issued in the upcoming listing [2]. - Ligent Technologies is also required to report on the progress of its overseas fundraising projects and compliance with overseas investment approval processes [2]. Group 4: Company Overview - Ligent Technologies is recognized as a leading global provider of optical communication and connection solutions, crucial for AI computing networks, and is one of the few companies with capabilities in both optical module and optical chip R&D and mass production [2].

Core Viewpoint - The China Securities Regulatory Commission (CSRC) has issued supplementary material requirements for five companies, including Jingcun Technology, which is preparing for an IPO on the Hong Kong Stock Exchange [1][2]. Group 1: Supplementary Material Requirements - Jingcun Technology is required to clarify issues related to equity changes, shareholder status, and business operations [1]. - The CSRC has requested a legal opinion from lawyers regarding the company's historical shareholding arrangements and the fairness of its employee stock ownership plan [1][2]. - The company must explain the basis for identifying its actual controller and whether the IPO could lead to changes in control [2]. Group 2: Business Operations - Jingcun Technology's business scope must be assessed for compliance with foreign investment restrictions, ensuring it meets regulatory requirements before and after the IPO [2]. - The company needs to clarify whether its arrangements for third-party payments adversely affect its operations and if they pose substantial obstacles to the IPO [2]. Group 3: Corporate Governance - The company must detail any failures to pay social insurance and housing funds, assessing whether these constitute significant legal violations impacting the IPO [2]. - Updates on any ongoing litigation and its effects on the company's operations and debt repayment capabilities must be provided [2]. Group 4: Company Overview - Jingcun Technology is an independent manufacturer of embedded storage products, focusing on the research, design, production, and sales of these products [3]. - Its product offerings include DRAM-based products (DDR, LPDDR), NAND Flash products (eMMC, UFS), and multi-chip package (MCP) embedded storage products [3]. - The company also provides testing and storage technology services as part of its storage solutions [3].

Group 1 - The China Securities Regulatory Commission (CSRC) has requested additional information from Puyuan Precision Electronics regarding its overseas investment compliance and foreign investment restrictions [1] - Puyuan Precision Electronics has submitted a listing application to the Hong Kong Stock Exchange, with CITIC Securities as the sole sponsor [1] - The CSRC's inquiries include the company's overseas subsidiary establishment procedures, compliance with foreign investment policies, and the operational status of its subsidiaries in restricted sectors [1] Group 2 - Puyuan Precision Electronics is a leading electronic measurement instrument company, recognized as the largest supplier in China and ranked eighth globally by revenue in 2024 [2] - The company designs, develops, manufactures, and delivers comprehensive electronic measurement instruments and solutions, supporting scientific exploration and industry innovation [2] - Through its "RIGOL" brand, the company serves over 100,000 end customers across more than 90 countries and regions, addressing complex testing challenges in various sectors including communications, new energy, semiconductors, and education [2]

Group 1 - The China Securities Regulatory Commission (CSRC) has requested additional information from Puyuan Precision Electronics regarding its overseas investment compliance and foreign investment restrictions [1] - Puyuan Precision Electronics has submitted a listing application to the Hong Kong Stock Exchange, with CITIC Securities as the sole sponsor [1] - The CSRC's inquiries include the company's overseas subsidiary establishment procedures, compliance with foreign investment policies, and the operational status of its subsidiaries in restricted sectors [1] Group 2 - Puyuan Precision Electronics is a leading electronic measurement instrument company, recognized as the largest supplier in China and ranked eighth globally by revenue in 2024 [2] - The company designs, develops, manufactures, and delivers comprehensive electronic measurement instruments and solutions, supporting scientific exploration and industry innovation [2] - Under the "RIGOL" brand, the company serves over 100,000 end customers across more than 90 countries and regions, addressing complex testing challenges in various sectors including communications, new energy, semiconductors, and education [2]

Group 1 - The China Securities Regulatory Commission (CSRC) has requested Shengbang Co., Ltd. to provide supplementary materials regarding its overseas listing application, specifically focusing on its technology export business over the past three years and compliance issues [1] - Shengbang Co., Ltd. has submitted its listing application to the Hong Kong Stock Exchange, with Huatai International and China International Capital Corporation as joint sponsors [1] - The CSRC requires that the materials submitted by Shengbang Co., Ltd. align with the contents of the prospectus, including details on the number of shares issued under different scenarios and the expected amount of funds raised [1] Group 2 - Shengbang Co., Ltd. is a comprehensive analog integrated circuit (IC) company that develops and sells high-performance analog ICs and sensors, which are fundamental components of all electronic systems [2] - As of September 21, 2025, the company has approximately 6,600 types of analog ICs and sensors across 36 product categories [2]

Group 1 - The China Securities Regulatory Commission (CSRC) has requested Shengbang Co., Ltd. to provide supplementary explanations regarding its subsidiary's "technology import and export" activities, specifically detailing the compliance and development status of its technology export business over the past three years [1] - Shengbang Co., Ltd. has submitted its listing application to the Hong Kong Stock Exchange, with Huatai International and CICC serving as joint sponsors [1] - The CSRC requires that the filing materials and the prospectus regarding the issuance and listing plan must be consistent, including details on the number of shares issued under the overallotment option and the expected fundraising amount [1] Group 2 - Shengbang Co., Ltd. is a comprehensive analog integrated circuit (IC) company that develops and sells high-performance analog ICs and sensors, which are fundamental components of all electronic systems [2] - As of September 21, 2025, the company has approximately 6,600 types of analog ICs and sensor products across 36 product categories [2]

Core Viewpoint - The China Securities Regulatory Commission (CSRC) has requested additional information from Aikobai regarding its compliance with stock incentive plans and reasons for not completing its overseas listing after previous approvals [1][2][3] Group 1: Regulatory Requirements - Aikobai is required to clarify the actual operations of its medical device production and business, including whether it has obtained the necessary qualifications and if its business scope involves areas listed in the "Negative List for Foreign Investment Access (2024 Edition)" [1] - The company must provide details on the regulatory procedures for overseas investments and foreign exchange management related to its overseas subsidiaries, along with a conclusive opinion on compliance [1] - Aikobai is also asked to explain the compliance of its implemented stock incentive plan, including the composition of participants, any relationships with other shareholders, and the legality and fairness of the plan [1] Group 2: Listing Status and Plans - The company needs to explain the reasons for not completing its overseas listing after previous approvals [3] - Aikobai is required to detail its prior A-share listing guidance and the reasons for withdrawing its application to the Shanghai Stock Exchange's Sci-Tech Innovation Board, including whether it plans to continue pursuing A-share listing and any potential impacts on the current listing [3] Group 3: Company Overview - Aikobai, established in 2013, is a biopharmaceutical company focused on discovering and developing therapies for respiratory and pediatric diseases [3] - The company has developed a pipeline of six candidate drugs, including its core product Qiruisuo Wei, which targets respiratory syncytial virus (RSV) infections, and other drugs in various clinical stages for conditions such as idiopathic pulmonary fibrosis (IPF) and attention deficit hyperactivity disorder (ADHD) [3]

Group 1 - The China Securities Regulatory Commission (CSRC) has requested Chipone Microelectronics (688630.SH) to provide additional information regarding its major shareholder, Aige Venture Capital, and the specific use of raised funds [1] - Chipone Microelectronics submitted its listing application to the Hong Kong Stock Exchange on August 31, 2025, with CICC as its sole sponsor [1] - The CSRC's inquiries include the basic situation of Aige Venture Capital, the company's business scope, and whether the raised funds will require overseas investment approvals [1] Group 2 - Chipone Microelectronics is a global leader in the direct-write lithography industry, providing core equipment for advanced information technology in the AI era [1] - The company has a complete R&D technology system that includes light sources, exposure engines, precision worktables, alignment and focusing, data links, and modular system integration design [2] - The product portfolio primarily consists of PCB direct imaging equipment and automatic line systems, as well as semiconductor direct-write lithography equipment and automatic line systems [2]